Kura Oncology Inc.

NASDAQ: KURA · Real-Time Price · USD
7.45
0.85 (12.88%)
At close: Aug 15, 2025, 2:34 PM

Kura Oncology Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-4.31 -6.9 -6.11 -7.15
PEG Ratio
1.50 -2.8 -2.01 -0.43
PS Ratio
13.93 n/a n/a n/a
PB Ratio
1.81 2.65 1.98 1.83
P/FCF Ratio
5.61 -8.42 -7.51 -8.79
P/OCF Ratio
5.59 -8.44 -7.55 -8.88
OCF/S Ratio
2.49 n/a n/a n/a
Debt / Equity Ratio
0.04 0.04 0.03 0.01
Quick Ratio
9.46 12.26 18.56 23.26
Current Ratio
9.46 12.26 18.56 23.26
Asset Turnover
0.07 n/a n/a n/a
Interest Coverage
-119.33 -107.04 -610.76 -318.4
Return on Equity
-0.42 -0.38 -0.32 -0.26
Return on Assets
-0.23 -0.34 -0.3 -0.24
Return on Invested Capital
-0.28 -0.4 -0.32 -0.25
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.98 n/a n/a n/a
Net Profit Margin
-3.23 n/a n/a n/a
Pretax Profit Margin
-3.19 n/a n/a n/a
Operating Profit Margin
-3.59 n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-3.15 n/a n/a n/a